Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Invasive Breast Cancer × atezolizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 18 Carcinoma, Hepatocellular 12 Small Cell Lung Carcinoma 9 Triple Negative Breast Neoplasms 7 Neoplasms 7 Breast Neoplasms 6 Urinary Bladder Neoplasms 4 Ovarian Neoplasms 4 Lung Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Transitional Cell 3 Melanoma 2 Colonic Neoplasms 2 Carcinoma 2 Venous Thrombosis 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Non-Small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases 1 Rectal Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non-Squamous Non-Small Cell Lung Cancer 1 Non-Small-Cell Lung 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms by Site 1

Interventions

Trastuzumab 2 Paclitaxel 2 Doxorubicin 2 Cyclophosphamide 2 pertuzumab 1 atezolizumab 1 Surgical Procedures, Operative 1 Lapatinib 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡